1334207-75-8

Basic information

• Product Name: (2S)-N^ω-(6-aminohexanoyl)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N^α-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]argininamide
• Synonyms: (2S)-N^ω-(6-aminohexanoyl)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N^α-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]argininamide
• CAS NO: 1334207-75-8
• Molecular Weight: 1009.22
• Mol File: 1334207-75-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2S)-N^ω-(6-aminohexanoyl)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N^α-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]argininamide(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-N^ω-(6-aminohexanoyl)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N^α-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]argininamide(1334207-75-8)
• EPA Substance Registry System: (2S)-N^ω-(6-aminohexanoyl)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N^α-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]argininamide(1334207-75-8)

Safety Data

• Hazardous Substances Data: 1334207-75-8(Hazardous Substances Data)

Upstream product

• 1334181-88-2 N-tert-butoxycarbonyl-N’-[6-(tert-butoxycarbonylamino)hexanoyl]-S-methylisothiourea 
• 6404-29-1 6-(tert-butoxycarbonylamino)hexanoic acid 
• 723-86-4 11-chloro-6-oxo-5,11-dihydro-6H-dibenzazepine 
• 723-87-5 11-hydroxy-6-oxo-5,11-dihydro-6H-dibenzazepine 
• 161422-37-3 4-(2-aminoethyl)-1,2-diphendiphenyl-1,2,4-triazolidine-3,5-dione 
• 246146-15-6 C₂₄H₁₈N₄O₄ 
• 1334181-81-5 ((2S)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N^α-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazine-1-yl]ethyl}cyclopentyl)acetyl]ornithinamide) 
• 1334182-45-4 (2S)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-Nα-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]-Nδ-phthaloylornithinamide 
• 149192-17-6 11-(piperazin-1-yl)-5,11-dihydrodibenzo[b,e]azepin-6-one 
• 1334182-30-7 C₆₅H₈₄N₁₂O₁₁ 
• 34877-12-8 1,2-diphenyl-1,2,4-triazolidine-3,5-dione 
• 122-66-7 diphenyl hydrazine 
• 84-65-1 9,10-phenanthrenequinone 
• 1143-50-6 5,6-dihydro-6,11-dioxomorphanthridine 

Downstream Products

• 1432471-20-9 (2S)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N^α-[2-(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]-N^ω-(6-propanoylaminohexanoyl)argininamide 

Relevant articles and documents

[3H]UR-PLN196: A Selective Nonpeptide Radioligand and Insurmountable Antagonist for the NeuropeptideY Y2Receptor

Radioing in on NPY: Attachment of a [2,3-3H]propionyl group through an appropriate linker to the guanidine group of an (S)-argininamide-type neuropeptideY (NPY) Y2 receptor antagonist resulted in a subtype-selective radioligand.